The availability of compounded GLP-1 drugs shifted after the FDA changed their regulations in April 2025. Here’s what to know.

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

This shift could improve care coordination and create opportunities for cost savings through enhanced formulary flexibility ...

FDA leaders under President Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public ...